OUR TURN-KEY™ MODEL

Specializing in Target-to-IND stage projects that require one of the following: 
 

• Create fresh NCE IP

• 100% small molecule expertise

• Create and expand discovery pipelines and IP portfolios

• Custom / challenging chemistry, proteomics and in vitro assays

• Turn-key support on program build-outs, fundraising, monetization and drug development